Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.4K
Overview
85.4K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

490
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
490
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

422
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

Chest·2026
Same author

Primary Graft Dysfunction after Lung Transplant in Mechanically Ventilated versus Extubated Patients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Airspace miR-146a levels in ventilated patients decrease with age and correlate with mortality.

bioRxiv : the preprint server for biology·2026
Same author

Critical illness expands a transcriptionally distinct hypometabolic CD8<sup>+</sup> T effector program associated with respiratory failure and mortality.

bioRxiv : the preprint server for biology·2026
Same author

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

The need for clarity among the shadows: It is time to further refine the definition of primary graft dysfunction in lung transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Related Experiment Video

Updated: Mar 9, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.2K

Primary graft dysfunction: pathophysiology to guide new preventive therapies.

Ciara M Shaver1, Lorraine B Ware1,2

  • 1a Department of Medicine , Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center , Nashville , TN , USA.

Expert Review of Respiratory Medicine
|January 12, 2017
PubMed
Summary

Primary graft dysfunction (PGD) after lung transplantation is a serious complication. This review explores risk factors and mechanisms, focusing on new strategies and molecular targets to prevent PGD.

Keywords:
Primary graft dysfunctionacute lung injurybiomarkersischemia-reperfusionlung transplantationpreventiontreatment

More Related Videos

Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model
08:46

Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model

Published on: June 27, 2018

8.6K
Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

908

Related Experiment Videos

Last Updated: Mar 9, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.2K
Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model
08:46

Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model

Published on: June 27, 2018

8.6K
Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

908

Area of Science:

  • Transplantation immunology
  • Pulmonary medicine
  • Critical care medicine

Background:

  • Primary graft dysfunction (PGD) is a frequent and serious complication following lung transplantation.
  • PGD presents as acute pulmonary edema, infiltrates, and hypoxemia within three days post-surgery.
  • Occurrence of PGD predicts adverse short- and long-term outcomes, yet prevention strategies are limited.

Purpose of the Study:

  • To review clinical and genetic risk factors associated with PGD development.
  • To summarize experimental findings on PGD mechanisms and injury pathways.
  • To highlight strategies for PGD risk reduction and identify novel molecular targets for prevention.

Main Methods:

  • Review of clinical data and genetic risk factors for PGD.
  • Analysis of basic and translational research on PGD mechanisms.
  • Exploration of ex vivo lung perfusion studies for therapeutic development.

Main Results:

  • Identified modifiable donor, recipient, and operative risk factors for PGD.
  • Elucidated biomarkers and mechanisms contributing to PGD.
  • Highlighted potential therapeutic targets for PGD prevention and treatment.

Conclusions:

  • Understanding PGD pathophysiology is crucial for developing new preventative and therapeutic agents.
  • Ex vivo lung perfusion offers a promising platform for rapid advancement of PGD therapeutics.
  • Targeting novel molecular pathways is essential for mitigating this complication.